$11.820
+0.468 (+3.96%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ABCL por análisis de gráficos similares
Alphio's ABCL stock price prediction model matches the current AbCellera Biologics Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.99 (+1.42%). The 1-week path is $12.46 (+5.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de AbCellera Biologics Inc.?
Abcellera Biologics Inc is a good buy right now. The current price is $11.82, with a forward P/E of 27.55, indicating growth potential despite recent losses. The stock has seen a 244.61% year-to-date change, reflecting strong market interest. The main risk is the negative net income, which was -$55,427,000 in Q2 2026, but the positive analyst outlook and clinical success suggest potential for recovery.
ABCL cerró en $11.82 el Friday, tras subir +3.96%
AbCellera Biologics Inc. (ABCL) last closed at $11.82, gaining +3.96%. These facts feed the 1-day and 1-week ABCL price prediction above.
Factores de la previsión
Los factores de la previsión de AbCellera Biologics Inc. (ABCL) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ABCL, ordenadas por similitud.
Análisis de estacionalidad de ABCL
Historically the probability of a positive October return for ABCL is 63.49%. September offers the highest probability of a positive month at 67.74%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ABCL
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $1.11 | $1.60 | $1.84 | -86.42% |
| Nov 2026 | $2.00 | $2.06 | $2.54 | -82.56% |
| Dec 2026 | $1.71 | $1.76 | $2.25 | -85.11% |
En 2026, se proyecta que AbCellera Biologics Inc. (ABCL) oscile entre $1.11 y $2.54.
Previsión mensual de AbCellera Biologics Inc. para 2026
En Oct de 2026, se proyecta que AbCellera Biologics Inc. promedie $1.60, con un mínimo de $1.11 y un máximo de $1.84.
En Nov de 2026, se proyecta que AbCellera Biologics Inc. promedie $2.06, con un mínimo de $2.00 y un máximo de $2.54.
En Dec de 2026, se proyecta que AbCellera Biologics Inc. promedie $1.76, con un mínimo de $1.71 y un máximo de $2.25.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.